What is the shelf life of the test?

The shelf life is between 24 and 36 months.

What payment terms are accepted?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

What is the lead time for orders?

The lead time is within 15 workdays for both peak and off seasons.

Wholesale Rapid (CEA) Carcinoembryonicag Test Uncut Sheet Rapid Test

Name: Wholesale Rapid (CEA) Carcinoembryonicag Test Uncut Sheet Rapid Test
Brand: Hebei Times Medical Technology Co., Ltd.
SKU: 1975058302

Hebei, ChinaHebei Times Medical Technology Co., Ltd.

US$0.90-25.00

1,000 Pieces

Sample price:US$10.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Reagent

Format

Strip/Cassette

Model NO.

USK-42

Size

30*6.0mm 30*8mm Customized

Certification

CE0123, ISO13485, Nmpa,FSC

MOQ

700

Name

Uncut Sheet Rapid Test

Principle of Test

Lmmunochromatographic Assay

Accuracy

99.9%

Strips

3mm/4mm

Transport Package

Plastic Bag, Sealed Carton

Specification

30*6/30*8/customized

Trademark

OEM/ Neutral

Origin

China

HS Code

3002150090

Production Capacity

1000000

Key features

High Accuracy Rate: Achieves 99.9% accuracy in detecting carcinoembryonic antigen.

Rapid Results: Delivers clear test results within 15-20 minutes.

Customizable Formats: Available in Strip or Cassette formats with customized sizes.

OEM & ODM Service: Supports custom cassette models and logo printing services.

Certified Quality: Holds CE, ISO13485, Nmpa, and FSC certifications.

Cost Effective: Provides safe, easy-to-use, and economical diagnostic solutions.

Long Shelf Life: Ensures product stability with a 24-36 month shelf life.

Extensive Options: Offers extensive testing marker options for various diseases.

Company profile

Hebei Times Medical Technology Co., Ltd.

Hebei, China

Business Type: Manufacturer/Factory, Trading Company CertifiedNearest Port: Shanghai Port, Beijing PortAverage Response Time: ≤3.51h CertifiedTerms of Payment: LC, T/T, D/P, etc. CertifiedInternational Commercial Terms(Incoterms): FOB, CIF, CFR

AI-Powered supplier vetting

SummaryHebei Times Medical Technology Co., Ltd. is identified as a China-based manufacturer/factory engaged in medical devices and in vitro diagnostic reagents, including urine test strips, infectious disease tests, uncut sheets, and related raw materials. The supplier reports ISO 9001 certification, 21–30 years of combined R&D engineer experience, 50 quality-control staff, and five production lines. It states that it has 14 years of industry experience, a mature supply chain, and partners in more than 50 countries, with customer deployments across multiple regions. However, the available trade records show only one transaction per listed period and a single associated buyer in Vietnam, so the breadth of independently evidenced customer cases and trading history remains limited. Evidence is insufficient to assess financial credibility, customization capability, or after-sales service in detail.

Supplier typeThe supplier is explicitly identified as Hebei Times Medical Technology Co., Ltd., a manufacturer/factory based in Hebei, China. Its stated business focuses on the research, development, and sales of medical devices and in vitro diagnostic reagents.

CertificationsThe supplier reports holding ISO 9001 certification. This provides explicit evidence of a certified quality-management system, although no additional certifications are stated.

R&D capabilityThe company states that it conducts research and development in medical devices and in vitro diagnostic reagents, and reports 21–30 years of total R&D engineer experience. Its product scope includes diagnostic tests and home-diagnosis products, supporting an R&D presence, but no specific patents, new-product results, or documented innovation achievements are provided.

Production capacityThe supplier is classified as a manufacturer/factory and reports five production lines, 50 quality-control staff, a mature supply chain, and quality control covering semi-finished products, plastic parts, accessories, and production equipment. These stated resources support production capability, although actual capacity utilization and delivery performance are not documented.